MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficac
- Cardio
- 18/05/2024
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
READ MOREMODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
READ MORENon-Invasive Technologies for Continuous Hemodynamic Monitoring in Clinical Use are on the Rise
READ MOREMedtronic's Affera™ System Shows Promising Safety and Efficacy in Atrial Fibrillation Treatment
READ MOREPhilips shows AI-powered cardiac monitoring benefits at Heart Rhythm Annual Meeting
READ MOREPhilips Announces Q1 Results Aligned with 2024 Plan, Settles Respironics Litigation for $1.1 Billion
READ MOREUnited Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™
READ MORECERENOVUS Launches Next Generation Catheter to Treat Acute Ischemic Stroke in Europe
READ MOREAvicenna.AI Secures FDA Clearance For Two Healthcare AI Solutions
READ MOREGilgamesh Pharma Wins $14M Grant to Develop Safer Ibogaine for Opioid Disorder
READ MOREAidoc and ACC Collaborate to Revolutionize Cardiovascular Care with Best-in-Class AI
READ MORE